We are live on ! Find out more
William Blair & Company

William Blair & Company Portfolio holdings

AUM $38.4B
1-Year Est. Return 25.71%
This Fund
S&P 500
This Quarter Est. Return
-2.96%
1 Year Est. Return
+25.71%
3 Year Est. Return
+88.7%
5 Year Est. Return
+104.53%
10 Year Est. Return
+665.86%
AUM
$21.8B
AUM Growth
-$767M
Cap. Flow
+$148M
Cap. Flow %
0.68%
Top 10 Hldgs %
23.44%
Holding
1,924
New
62
Increased
766
Reduced
660
Closed
101

Top Sells

Rank Stock Value
1
TEAM icon
Atlassian
TEAM
+$77.8M
2
TREX icon
Trex
TREX
+$39.7M
3
DOCU
DocuSign
DOCU
+$17.2M
4
AKAM icon
Akamai
AKAM
+$16.6M
5
GLD icon
SPDR Gold Trust
GLD
+$13.1M

Sector Composition

Rank Sector Weight
1 Technology 23.15%
2 Healthcare 19.33%
3 Financials 11.9%
4 Industrials 11.25%
5 Consumer Discretionary 9.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BELFB
1326
Bel Fuse Inc Class B
BELFB
$4.25B
$231K ﹤0.01%
+9,150
New +$215K
NWL icon
1327
Newell Brands
NWL
$2.65B
$230K ﹤0.01%
16,538
+333
+2% +$6.22K
SRCL
1328
DELISTED
Stericycle Inc
SRCL
$229K ﹤0.01%
5,439
-1,510
-22% -$72.7K
ALLE icon
1329
Allegion
ALLE
$13.9B
$228K ﹤0.01%
2,544
-89
-3% -$8.81K
FTS icon
1330
Fortis
FTS
$28.8B
$228K ﹤0.01%
6,011
+114
+2% +$5.16K
PPLI
1331
People Inc
PPLI
$2.99B
$228K ﹤0.01%
5,017
-297
-6% -$16.7K
ATO icon
1332
Atmos Energy
ATO
$28.7B
$227K ﹤0.01%
2,231
+41
+2% +$4.7K
DLS icon
1333
WisdomTree International SmallCap Dividend Fund
DLS
$1.08B
$227K ﹤0.01%
+4,420
New +$257K
NARI
1334
DELISTED
Inari Medical, Inc. Common Stock
NARI
$227K ﹤0.01%
3,130
MYGN icon
1335
Myriad Genetics
MYGN
$303M
$226K ﹤0.01%
11,869
-214
-2% -$4.91K
AYI icon
1336
Acuity Brands
AYI
$10.7B
$225K ﹤0.01%
1,427
-21
-1% -$3.55K
RPV icon
1337
Invesco S&P 500 Pure Value ETF
RPV
$1.74B
$225K ﹤0.01%
3,218
XLG icon
1338
Invesco S&P 500 Top 50 ETF
XLG
$11B
$225K ﹤0.01%
8,370
+920
+12% +$27.7K
MNST icon
1339
Monster Beverage
MNST
$91.9B
$224K ﹤0.01%
10,316
+464
+5% +$10.7K
AGI icon
1340
Alamos Gold
AGI
$13.6B
$223K ﹤0.01%
30,122
+27
+0.1% +$200
NFRA icon
1341
FlexShares STOXX Global Broad Infrastructure Index Fund
NFRA
$3.04B
$223K ﹤0.01%
4,884
-43
-0.9% -$2.23K
FINX icon
1342
Global X FinTech ETF
FINX
$168M
$222K ﹤0.01%
10,953
+50
+0.5% +$1.18K
UI icon
1343
Ubiquiti
UI
$35B
$222K ﹤0.01%
+755
New +$223K
VIRX
1344
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$221K ﹤0.01%
51,843
LHCG
1345
DELISTED
LHC Group LLC
LHCG
$221K ﹤0.01%
1,352
-758
-36% -$123K
SHYG icon
1346
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
$7.62B
$220K ﹤0.01%
5,498
+3,906
+245% +$161K
FAF icon
1347
First American
FAF
$7.44B
$218K ﹤0.01%
4,740
+5
+0.1% +$270
MSTR icon
1348
Strategy Inc
MSTR
$37.5B
$218K ﹤0.01%
+10,290
New +$258K
JJSF icon
1349
J&J Snack Foods
JJSF
$1.69B
$216K ﹤0.01%
1,669
-4,734
-74% -$673K
SIRI icon
1350
SiriusXM
SIRI
$9.54B
$216K ﹤0.01%
3,786
-772
-17% -$48.5K

Similar funds

William Blair & Company's Q3 2022 Portfolio in Review

As of Q3 2022, William Blair & Company held 1,924 positions worth $21.8B, down 3.4% from $22.5B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

William Blair & Company's Q3 2022 filing shows 62 new, 766 increased, 660 reduced and 101 closed positions. Its largest new stake was GSK: 37,792 shares worth $1.11M. The largest sale was Atlassian, an estimated $77.8M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.

  • William Blair & Company's largest Q3 2022 buy was GSK: 37,792 shares worth $1.11M.
  • William Blair & Company added most to Watsco Inc in Q3 2022, an estimated $31.3M increase.
  • William Blair & Company's biggest Q3 2022 reduction was Trex, cutting an estimated $39.7M.
  • William Blair & Company fully exited Atlassian in Q3 2022, selling an estimated $77.8M.
  • William Blair & Company's ten largest holdings make up 23% of its $21.8B portfolio in Q3 2022.
  • William Blair & Company opened 62 new positions and closed 101 in Q3 2022.
  • William Blair & Company's portfolio value fell 3.4% quarter-over-quarter to $21.8B.

Based on William Blair & Company's 13F filing for Q3 2022, filed 9 Nov 2022.